Valuation: Edwards Lifesciences Corporation

Capitalization 4.67TCr 3.96TCr 3.64TCr 3.44TCr 6.38TCr 4,32100Cr 6.5TCr 43TCr 17TCr 2,09400Cr 18TCr 17TCr 7,38200Cr P/E ratio 2026 *
28x
P/E ratio 2027 * 25.6x
Enterprise value 4.2TCr 3.55TCr 3.27TCr 3.1TCr 5.74TCr 3,88300Cr 5.84TCr 38TCr 15TCr 1,88200Cr 16TCr 15TCr 6,63400Cr EV / Sales 2026 *
6.29x
EV / Sales 2027 * 5.52x
Free-Float
89.32%
Yield 2026 *
-
Yield 2027 * -
1 day+2.45%
1 week+4.01%
Current month+1.14%
1 month-3.89%
3 months-3.98%
6 months+8.51%
Current year-5.00%
1 week 77.1
Extreme 77.1
81.69
1 month 77.1
Extreme 77.1
83.83
Current year 74.66
Extreme 74.66
87.32
1 year 68.63
Extreme 68.63
87.89
3 years 58.93
Extreme 58.93
96.12
5 years 58.93
Extreme 58.93
131.73
10 years 27.04
Extreme 27.04
131.73
Manager TitleAgeSince
Chief Executive Officer 58 11/05/2023
Director of Finance/CFO 59 01/01/2014
Chief Tech/Sci/R&D Officer - 01/02/2019
Director TitleAgeSince
Chairman 69 07/05/2024
Director/Board Member 62 10/02/2015
Director/Board Member 58 11/05/2023
Change 5d. change 1-year change 3-years change Capi.($)
+2.45%+4.01%+13.23%-3.64% 4.56TCr
+2.05%+6.15%+23.18%-10.53% 19TCr
+2.43%+4.13%-2.80%+74.50% 16TCr
+0.50%+2.71%+4.24%-23.85% 14TCr
+1.28%+3.95%-32.47%+24.14% 9.43TCr
+1.46%+3.02%-12.88%-27.51% 5.04TCr
+3.06%+5.92%+18.92%-13.07% 3.34TCr
+1.99%+2.02%+19.70%-9.74% 3.34TCr
+1.51%-0.33%+7.14%+1.18% 3.26TCr
+2.74%+2.43%+2.11%+5.87% 3.13TCr
Average +1.78%+2.90%+4.04%+1.73% 8.13TCr
Weighted average by Cap. +1.47%+3.22%+3.76%+8.63%

Financials

2026 *2027 *
Net sales 667.47Cr 565.41Cr 520.24Cr 492.36Cr 912.5Cr 62TCr 928.53Cr 6.09TCr 2.39TCr 30TCr 2.5TCr 2.45TCr 1,05500Cr 733.49Cr 621.34Cr 571.7Cr 541.07Cr 1TCr 68TCr 1.02TCr 6.7TCr 2.63TCr 33TCr 2.75TCr 2.69TCr 1,16000Cr
Net income 167.56Cr 141.94Cr 130.6Cr 123.6Cr 229.07Cr 16TCr 233.1Cr 1.53TCr 599.75Cr 7.52TCr 628.54Cr 615.46Cr 26TCr 182.78Cr 154.83Cr 142.46Cr 134.83Cr 249.88Cr 17TCr 254.27Cr 1.67TCr 654.24Cr 8.2TCr 685.64Cr 671.38Cr 29TCr
Net Debt -473.32Cr -400.95Cr -368.92Cr -349.15Cr -647.09Cr -44TCr -658.45Cr -4.32TCr -1.69TCr -21TCr -1.78TCr -1.74TCr -75TCr -619.42Cr -524.71Cr -482.79Cr -456.92Cr -846.81Cr -57TCr -861.69Cr -5.65TCr -2.22TCr -28TCr -2.32TCr -2.28TCr -98TCr
Logo Edwards Lifesciences Corporation
Edwards Lifesciences Corporation specializes in designing, manufacturing and marketing medical systems and devices for treating cardiovascular diseases. Net sales break down by family of products as follows: - heart valves and surgery products (74%); - hemodynamic monitoring systems (9.1%); - other (16.9%): balloon catheters, artificial implants, etc. Net sales are distributed geographically as follows: the United States (58.4%), Europe (25%), Japan (5.8%) and other (10.8%).
Employees
16,000
Date Price Change Volume
17/26/17 80.99 $ +2.45% 55,55,159
16/26/16 79.05 $ +1.09% 61,92,791
15/26/15 78.20 $ 0.00% 51,28,511
14/26/14 78.20 $ +0.10% 58,59,782
13/26/13 78.12 $ +0.32% 63,03,264
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
30
Last Close Price
80.99USD
Average target price
96.33USD
Spread / Average Target
+18.94%

Quarterly revenue - Rate of surprise